+Susen Rogen

Friday, 20 September 2013

Romania Pharmaceuticals and Healthcare Report Q4 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports
 
Curious about BaaS?

Get the full feature comparison in our free eBook comparing the time to create your own cloud backend to a Backend as a Service like Kinvey.
From our sponsors
Romania Pharmaceuticals and Healthcare Report Q4 2013
Sep 18th 2013, 00:00, by swapnil

BMI View: We forecast continued growth in Romania’s pharmaceutical market due to greater private contributions to the cost of healthcare and a return to slight economic growth in 2013. The partial removal of elements of the claw-back tax will undoubtedly provide the industry with a slight boost this year, as will pressure from creditors to repay debts and companies on time. However, the delaying of changes to the reimbursement list until January 2014 will moderate the growth of patented and prescription medicines in 2013. These issues continue to weigh down BMI’s assessment of Romania’s Pharmaceutical and Healthcare Risk/Reward ratings. Headline …

Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=116117.

Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/romania-pharmaceuticals-and-healthcare-report-q4-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment